{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:02:18Z","timestamp":1792674138275,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T00:00:00Z","timestamp":1471824000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s11920-016-0727-9","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T05:46:24Z","timestamp":1471844784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":158,"title":["Benzodiazepine Misuse in the Elderly: Risk Factors, Consequences, and Management"],"prefix":"10.1007","volume":"18","author":[{"given":"Guillaume","family":"Airagnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Pelissolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Lavall\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Flament","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Limosin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,22]]},"reference":[{"issue":"2","key":"727_CR1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/bcp.12023","volume":"77","author":"SD Hood","year":"2014","unstructured":"Hood SD, Norman A, Hince DA, Melichar JK, Hulse GK. Benzodiazepine dependence and its treatment with low dose flumazenil. Br J Clin Pharmacol. 2014;77(2):285\u201394.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"727_CR2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/fampra\/cmt010","volume":"30","author":"IA Willems","year":"2013","unstructured":"Willems IA, Gorgels WJ, Oude Voshaar RC, Mulder J, Lucassen PL. Tolerance to benzodiazepines among long-term users in primary care. Fam Pract. 2013;30(4):404\u201310.","journal-title":"Fam Pract"},{"issue":"1","key":"727_CR3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eurpsy.2011.11.003","volume":"28","author":"B Dell\u2019osso","year":"2011","unstructured":"Dell\u2019osso B, Lader M. Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. Eur Psychiatry. 2011;28(1):7\u201320.","journal-title":"Eur Psychiatry"},{"issue":"11","key":"727_CR4","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.clinthera.2014.10.007","volume":"36","author":"MM Garrido","year":"2014","unstructured":"Garrido MM, Prigerson HG, Penrod JD, Jones SC, Boockvar KS. Benzodiazepine and sedative-hypnotic use among older seriously ill veterans: choosing wisely? Clin Ther. 2014;36(11):1547\u201354.","journal-title":"Clin Ther"},{"issue":"3","key":"727_CR5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cger.2014.04.008","volume":"30","author":"A Kuerbis","year":"2014","unstructured":"Kuerbis A, Sacco P, Blazer DG, Moore AA. Substance abuse among older adults. Clin Geriatr Med. 2014;30(3):629\u201354.","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"727_CR6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.archger.2011.07.001","volume":"55","author":"C-L Liu","year":"2011","unstructured":"Liu C-L, Peng L-N, Chen Y-T, Lin M-H, Liu L-K, Chen L-K. Potentially inappropriate prescribing (IP) for elderly medical inpatients in Taiwan: a hospital-based study. Arch Gerontol Geriatr. 2011;55(1):148\u201351.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"727_CR7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.genhosppsych.2010.12.004","volume":"33","author":"L Spanemberg","year":"2010","unstructured":"Spanemberg L, Nogueira EL, Belem da Silva CT, Darg\u00e9l AA, Menezes FS, Neto AC. High prevalence and prescription of benzodiazepines for elderly: data from psychiatric consultation to patients from an emergency room of a general hospital. Gen Hosp Psychiatry. 2010;33(1):45\u201350.","journal-title":"Gen Hosp Psychiatry"},{"issue":"7","key":"727_CR8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.sleep.2011.12.014","volume":"13","author":"CI Neutel","year":"2011","unstructured":"Neutel CI, Skurtveit S, Berg C. What is the point of guidelines? Benzodiazepine and z-hypnotic use by an elderly population. Sleep Med. 2011;13(7):893\u20137.","journal-title":"Sleep Med"},{"issue":"1","key":"727_CR9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijge.2014.03.009","volume":"9","author":"S Vaapio","year":"2015","unstructured":"Vaapio S, Puustinen J, Salminen MJ, Vahlberg T, Salonoja M, Lyles A, et al. Symptoms associated with long-term benzodiazepine use in elderly individuals aged 65 years and older: a longitudinal descriptive study. Int J Gerontol. 2015;9(1):34\u20139.","journal-title":"Int J Gerontol"},{"issue":"4","key":"727_CR10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.encep.2010.04.016","volume":"36","author":"M Bourin","year":"2010","unstructured":"Bourin M. The problems with the use of benzodiazepines in elderly patients. Enc\u00e9phale. 2010;36(4):340\u20137.","journal-title":"Enc\u00e9phale"},{"issue":"10","key":"727_CR11","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1046\/j.1532-5415.2001.49262.x","volume":"49","author":"K Tu","year":"2001","unstructured":"Tu K, Mamdani MM, Hux JE, Tu JB. Progressive trends in the prevalence of benzodiazepine prescribing in older people in Ontario, Canada. J Am Geriatr Soc. 2001;49(10):1341\u20135.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"727_CR12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.eurger.2012.04.007","volume":"3","author":"E Holm","year":"2012","unstructured":"Holm E, Fosbol E, Pedersen H, Jensen TB, Nielsen M, Weeke P, et al. Benzodiazepine use in Denmark 1997\u20132008. Eur Geriatr Med. 2012;3(5):299\u2013303.","journal-title":"Eur Geriatr Med"},{"issue":"2","key":"727_CR13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcgg.2012.12.001","volume":"4","author":"F-Y Hsiao","year":"2013","unstructured":"Hsiao F-Y, Hsieh P-H, Gau C-S. Ten-year trend in prescriptions of z-hypnotics among the elderly: a nationwide, cross-sectional study in Taiwan. J Clin Gerontol Geriatr. 2013;4(2):37\u201341.","journal-title":"J Clin Gerontol Geriatr"},{"key":"727_CR14","doi-asserted-by":"crossref","first-page":"h2698","DOI":"10.1136\/bmj.h2698","volume":"350","author":"TW Park","year":"2015","unstructured":"Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert ASB. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ. 2015;350:h2698.","journal-title":"BMJ"},{"issue":"4","key":"727_CR15","first-page":"489","volume":"12","author":"S Singh","year":"2014","unstructured":"Singh S, Bajorek B. Defining \u2018elderly\u2019 in clinical practice guidelines for pharmacotherapy. Pharm Pract. 2014;12(4):489.","journal-title":"Pharm Pract"},{"key":"727_CR16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1745691614556680","volume":"10","author":"MK Scullin","year":"2015","unstructured":"Scullin MK, Bliwise DL. Sleep, cognition, and normal aging: integrating a half century of multidisciplinary research. Perspect Psychol Sci. 2015;10:97\u2013137.","journal-title":"Perspect Psychol Sci"},{"issue":"1","key":"727_CR17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jns.2015.02.050","volume":"351","author":"M Yamada","year":"2015","unstructured":"Yamada M, Landes RD, Mimori Y, Nagano Y, Sasaki H. Trajectories of cognitive function in dementia-free subjects: radiation effects research foundation adult health study. J Neurol Sci. 2015;351(1):115\u20139.","journal-title":"J Neurol Sci"},{"issue":"3","key":"727_CR18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.revmed.2011.11.016","volume":"33","author":"M Andro","year":"2012","unstructured":"Andro M, Estivin S, Gentric A. Medicinal prescriptions in geriatrics: overuse, misuse, underuse. Qualitative analysis from the prescriptions of 200 patients admitted in an acute care geriatric unit. Rev Med Interne. 2012;33(3):122\u20137.","journal-title":"Rev Med Interne"},{"issue":"5","key":"727_CR19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/jcpt.12178","volume":"39","author":"L Pasina","year":"2014","unstructured":"Pasina L, Djade CD, Tettamanti M, Franchi C, Salerno F, Corrao S, et al. Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients: results from the REPOSI study. J Clin Pharm Ther. 2014;39(5):511\u20135.","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"727_CR20","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","volume":"60","author":"The American Geriatrics Society Beers Criteria Update Expert Panel","year":"2012","unstructured":"The American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616\u201331.","journal-title":"J Am Geriatr Soc"},{"issue":"22","key":"727_CR21","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","volume":"163","author":"DM Fick","year":"2003","unstructured":"Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716\u201324.","journal-title":"Arch Intern Med"},{"key":"727_CR22","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5\u00ae). American Psychiatric Publishing; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"4","key":"727_CR23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jsr.2012.08.009","volume":"43","author":"LJ Paulozzi","year":"2012","unstructured":"Paulozzi LJ. Prescription drug overdoses: a review. J Saf Res. 2012;43(4):283\u20139.","journal-title":"J Saf Res"},{"issue":"7\u20138","key":"727_CR24","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3109\/10826080903550521","volume":"45","author":"V Aubron","year":"2010","unstructured":"Aubron V, Camus V, Bouazzaoui B, Pelissolo A, Michel G. Psychotropic drug use among the elderly: risk factors involved in long-term use. Subst Use Misuse. 2010;45(7\u20138):1050\u20139.","journal-title":"Subst Use Misuse"},{"issue":"5","key":"727_CR25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000434755","volume":"84","author":"JM Cloos","year":"2015","unstructured":"Cloos JM, Bocquet V, Rolland-Portal I, Koch P, Chouinard G. Hypnotics and triazolobenzodiazepines\u2014best predictors of high-dose benzodiazepine use: results from the Luxembourg national health insurance registry. Psychother Psychosom. 2015;84(5):273\u201383.","journal-title":"Psychother Psychosom"},{"issue":"8","key":"727_CR26","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00228-013-1506-8","volume":"69","author":"F Montastruc","year":"2013","unstructured":"Montastruc F, Gardette V, Cantet C, Piau A, Lapeyre-Mestre M, Vellas B, et al. Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs! Eur J Clin Pharmacol. 2013;69(8):1589\u201397.","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"727_CR27","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/gps.3769","volume":"27","author":"PB Rosenberg","year":"2012","unstructured":"Rosenberg PB, Mielke MM, Han D, Leoutsakos JS, Lyketsos CG, Rabins PV, et al. The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer\u2019s disease. Int J Geriatr Psychiatry. 2012;27(12):1248\u201357.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"727_CR28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.maturitas.2013.01.004","volume":"74","author":"AM Strien Van","year":"2013","unstructured":"Van Strien AM, Koek HL, van Marum RJ, Emmelot-Vonk MH. Psychotropic medications, including short acting benzodiazepines, strongly increase the frequency of falls in elderly. Maturitas. 2013;74(4):357\u201362.","journal-title":"Maturitas"},{"issue":"1","key":"727_CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mpmed.2012.10.011","volume":"41","author":"A Anand","year":"2012","unstructured":"Anand A, MacLullich AMJ. Delirium in hospitalized older adults. Medicine. 2012;41(1):39\u201342.","journal-title":"Medicine"},{"issue":"21","key":"727_CR30","first-page":"391","volume":"109","author":"S Lorenzl","year":"2012","unstructured":"Lorenzl S, Fusgen I, Noachtar S. Acute confusional states in the elderly\u2014diagnosis and treatment. Dtsch Arztebl Int. 2012;109(21):391\u20139. quiz 400.","journal-title":"Dtsch Arztebl Int"},{"issue":"7","key":"727_CR31","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2014.93","volume":"311","author":"AP Porsteinsson","year":"2014","unstructured":"Porsteinsson AP, Drye LT, Pollock BG, et al. Effect of citalopram on agitation in Alzheimer disease: the citad randomized clinical trial. JAMA. 2014;311(7):682\u201391.","journal-title":"JAMA"},{"key":"727_CR32","first-page":"CD008191","volume":"2","author":"DP Seitz","year":"2011","unstructured":"Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P. Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst Rev. 2011;2:CD008191.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"727_CR33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1183\/09031936.00008014","volume":"44","author":"NT Vozoris","year":"2014","unstructured":"Vozoris NT, Fischer HD, Wang X, Stephenson AL, Gershon AS, Gruneir A, et al. Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J. 2014;44(2):332\u201340.","journal-title":"Eur Respir J"},{"issue":"1","key":"727_CR34","first-page":"8","volume":"336","author":"T Harnod","year":"2013","unstructured":"Harnod T, Lin C-L, Sung F-C, Kao C-H. An association between benzodiazepine use and occurrence of benign brain tumors. J Neurol Sci. 2013;336(1):8\u201312.","journal-title":"J Neurol Sci"},{"key":"727_CR35","doi-asserted-by":"crossref","unstructured":"Iqbal U, Nguyen PA, Syed-Abdul S, Yang HC, Huang CW, Jian WS, et al. Is long-term use of benzodiazepine a risk for cancer? Medicine. 2015;94(6):e483. This case\u2013control study among 42,500 cases of cancer over 12\u00a0years found an association between clonazepam consumption and an increased risk of cancer, such as brain, colorectal and lung cancers.","DOI":"10.1097\/MD.0000000000000483"},{"key":"727_CR36","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","volume":"349","author":"S Billioti de Gage","year":"2014","unstructured":"Billioti de Gage S, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, et al. Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study. BMJ. 2014;349:g5205. This is the first case-control study, in a large cohort and with an acceptable methodology, which addressed the issue of a potential association between Alzheimer disease (AD) and BZD consumption; 1,796 elderly with AD were matched with 7184 controls; BZD ever use was associated with an increased risk of AD.","journal-title":"BMJ"},{"issue":"3","key":"727_CR37","first-page":"280","volume":"1","author":"DP Cardinali","year":"2012","unstructured":"Cardinali DP, Vigo DE, Olivar N, Vidal MF, Furio AM, Brusco LI. Therapeutic application of melatonin in mild cognitive impairment. Am J Neurodegener Dis. 2012;1(3):280\u201391.","journal-title":"Am J Neurodegener Dis"},{"issue":"4\u20135","key":"727_CR38","first-page":"145","volume":"47","author":"M Tveito","year":"2014","unstructured":"Tveito M, Lorentzen B, Engedal K, Tanum L, Bramness JG, Refsum H, et al. Changes in cognitive function during psychogeriatric treatment in relation to benzodiazepine cessation. Pharmacopsychiatry. 2014;47(4\u20135):145\u201350.","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"727_CR39","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.euroneuro.2012.05.004","volume":"23","author":"T Mura","year":"2012","unstructured":"Mura T, Proust-Lima C, Akbaraly T, Amieva H, Tzourio C, Chevassus H, et al. Chronic use of benzodiazepines and latent cognitive decline in the elderly: results from the three-city study. Eur Neuropsychopharmacol. 2012;23(3):212\u201323.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"727_CR40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S0033291704003897","volume":"35","author":"H Verdoux","year":"2005","unstructured":"Verdoux H, Lagnaoui R, Begaud B. Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychol Med. 2005;35(3):307\u201315.","journal-title":"Psychol Med"},{"key":"727_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-015-0319-3","author":"P Imfeld","year":"2015","unstructured":"Imfeld P, Bodmer M, Jick SS, Meier CR. Benzodiazepine use and risk of developing Alzheimer\u2019s disease or vascular dementia: a case-control analysis. Drug Saf. 2015. doi: 10.1007\/s40264-015-0319-3 .","journal-title":"Drug Saf"},{"issue":"1","key":"727_CR42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pec.2013.02.016","volume":"92","author":"P Martin","year":"2013","unstructured":"Martin P, Tamblyn R, Ahmed S, Tannenbaum C. A drug education tool developed for older adults changes knowledge, beliefs and risk perceptions about inappropriate benzodiazepine prescriptions in the elderly. Patient Educ Couns. 2013;92(1):81\u20137. Authors developed an educational tool targeted directly to older consumers on the risks associated with BZD use in the geriatric population. They aimed to increase the patient\u2019s risk perception by eliciting cognitive dissonance through knowledge acquisition and belief restructuration. They found a significant enhancement of self-reported change in perception of risk associated with BZD use in the intervention group.","journal-title":"Patient Educ Couns"},{"issue":"10","key":"727_CR43","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00228-014-1725-7","volume":"70","author":"J Bourgeois","year":"2014","unstructured":"Bourgeois J, Elseviers M, Van Bortel L, Petrovic M, Stichele RV. Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study. Eur J Clin Pharmacol. 2014;70(10):1251\u201360.","journal-title":"Eur J Clin Pharmacol"},{"key":"727_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.12521","author":"DK Miu","year":"2015","unstructured":"Miu DK, Chan CW, Kok C. Delirium among elderly patients admitted to a post-acute care facility and 3-months outcome. Geriatr Gerontol Int. 2015. doi: 10.1111\/ggi.12521 .","journal-title":"Geriatr Gerontol Int"},{"issue":"5","key":"727_CR45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s40263-014-0163-5","volume":"28","author":"EC Perry","year":"2014","unstructured":"Perry EC. Inpatient management of acute alcohol withdrawal syndrome. CNS Drugs. 2014;28(5):401\u201310.","journal-title":"CNS Drugs"},{"issue":"3","key":"727_CR46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jsat.2011.12.011","volume":"43","author":"SS Kawasaki","year":"2011","unstructured":"Kawasaki SS, Jacapraro JS, Rastegar DA. Safety and effectiveness of a fixed-dose phenobarbital protocol for inpatient benzodiazepine detoxification. J Subst Abuse Treat. 2011;43(3):331\u20134.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"727_CR47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1192\/bjp.bp.113.126003","volume":"204","author":"RL Gould","year":"2014","unstructured":"Gould RL, Coulson MC, Patel N, Highton-Williamson E, Howard RJ. Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials. Br J Psychiatry. 2014;204(2):98\u2013107. This meta-analysis reviewed the evidence for interventions aimed at reducing BZD use in older people. Authors included 10 BZD withdrawal studies and 8 changing prescription studies in which participants were 60 years or more, with 50 years as the minimum age. Withdrawal augmented with psychotherapy was the only intervention associated with withdrawal at 12 months follow-up.","journal-title":"Br J Psychiatry"},{"issue":"3","key":"727_CR48","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.jad.2011.10.016","volume":"136","author":"VRK J\u00f8rgensen","year":"2011","unstructured":"J\u00f8rgensen VRK. Benzodiazepine reduction in general practice. Are the elderly neglected? J Affect Disord. 2011;136(3):1216\u201321. doi: 10.1016\/j.jad.2011.10.016 .","journal-title":"J Affect Disord"},{"issue":"7","key":"727_CR49","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1517\/14740338.2014.925444","volume":"13","author":"AM Paquin","year":"2014","unstructured":"Paquin AM, Zimmerman K, Rudolph JL. Risk versus risk: a review of benzodiazepine reduction in older adults. Expert Opin Drug Saf. 2014;13(7):919\u201334.","journal-title":"Expert Opin Drug Saf"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-016-0727-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-016-0727-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-016-0727-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T20:44:29Z","timestamp":1568321069000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-016-0727-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,22]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["727"],"URL":"https:\/\/doi.org\/10.1007\/s11920-016-0727-9","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,22]]},"article-number":"89"}}